GIA
AGN

Gateway Investment Advisers’s Allergan Inc AGN Stock Holding History

Gateway Investment Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-35,651
Closed -$7.58M – 654
2014
Q4 		$7.58M Sell
35,651
-9,334
-21% -$1.86M 0.06% 228
2014
Q3 		$8.02M Sell
44,985
-594
-1% -$98.7K 0.06% 231
2014
Q2 		$7.71M Buy
45,579
+3,212
+8% +$500K 0.06% 230
2014
Q1 		$5.26M Sell
42,367
-1,260
-3% -$153K 0.04% 269
2013
Q4 		$4.85M Sell
43,627
-1,550
-3% -$148K 0.04% 274
2013
Q3 		$4.09M Buy
45,177
+1,046
+2% +$93.9K 0.03% 284
2013
Q2 		$3.72M Buy
+44,131
New +$4.58M 0.03% 292

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Gateway Investment Advisers's AGN Position: Q1 2015 in Review

Gateway Investment Advisers sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 35,651 shares — an estimated $7.58M sold.

Gateway Investment Advisers first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $8.02M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Gateway Investment Advisers reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Gateway Investment Advisers sold 35,651 Allergan Inc shares in Q1 2015, an estimated $7.58M.
  • Gateway Investment Advisers first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Gateway Investment Advisers's Allergan Inc position peaked at $8.02M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Gateway Investment Advisers's 13F filing for Q1 2015, filed 21 Apr 2015.